XML 33 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narratives) (Details) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Other current assets $ 190,000   $ 105,000
Current prepaid expense 100,000    
Other current receivables $ 100,000    
Share-based compensation arrangement by share-based payment award, expiration period 10 years    
Stock-based compensation expense $ (24,000) $ 110,000  
Unrecognized compensation expense related to unvested stock awards, not yet recognized $ 100,000    
Unvested stock options, unrecognized compensation expense weighted average recognition period 1 year    
Common stock rights issued (in shares) 2,933,106    
Deferred revenue $ 133,000   170,000
Options, warrants and conversion rights, common stock callable and antidilutive (in shares) 4,425,218 12,970,881  
Pharmacogenomic Services      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Deferred revenue $ 100,000   $ 200,000
Executive Officers      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock options, unvested options, vesting period 3 years    
Common stock rights issued (in shares) 83,333    
Selling, General and Administrative Expenses      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense $ 0 $ 100,000  
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock options, unvested options, vesting period 3 years